多廿醇治疗心血管疾病的研究进展
作者：庞伟毅;韦小敏;
Author：
收稿日期： 年卷（期）页码：2008,(04):-456-458
期刊名称：华西药学杂志
Journal Name：WEST CHINA JOURNAL OF PHARMACEUTICAL SCIENCES
关键字：多廿醇;心血管疾病;临床研究;基础研究;作用机制
Key words：
基金项目：国家自然科学基金课题(批准号:30360091)
中文摘要
综述多廿醇在治疗心血管疾病方面的临床及基础研究,探讨其可能涉及的机制。
参考文献
[1]Arruzazabala ML,Noa M,Menendez R,et al.Protective effect ofpolicosanol on atherosclerotic lesions in rabbits with exogenoushypercholesterolemia[J].Braz J Med Biol Res,2000,33(7):835-840.
[2]Gouni-berthold I,Berthold HK.Policosanol:clinical phartau-tology and therapeutic significance of a newlipid,lowering agent[J].Am Heart,2002,143(2):356-365.
[3]Mccarty MF.An ezetimibe-policosanol combination has the po-tential to be an OTC agent that could dramatically lower LDLcho-lesterol without side effects[J].Med Hypotheses,2005,64(3):636-645.
[4]Tedeschi-reiner E,Reiner Z,Remic Z,et al.A randomized,double-blind,placebo-controlled study of theantilipemic effi-cacy and tolerability of food supplement policosanol in patientswith moderate hypercholesterolemia[J].Lijec Vjesn,2005,127(11-12):273-279.
[5]Castano,Gladys,MAS,et al.Comparison of the Efficacy and Tol-erability of Policosanol with Atorvastatin in Elderly Patients withType II Hypercholesterolaemia[J].Drugs&Aging,2003,20(2):153-163.
[6]崔艳丽,赵秀丽,武峰,等.胆固醇酯转运蛋白基因Taq多态性与多廿烷醇降脂疗效的关系[J].中国新药杂志,2007,16(3):240-243.
[7]Mirkin A,Mas R,Martinto M,et al.Efficacy and tolerability ofpolicosanol in hypercholesterolemic postmenopausal women[J].Int J Clin Pharmacol Res,2001,21(1):31-41.
[8]Mas R,Castano G,Fernandez L,et al.Effects of Policosanol onLipid Profile and Cardiac Events in Older HypercholesterolaemicPatients with Coronary Disease[J].Clin Drug Inv,2001,21(7):485-497.
[9]Arruzazabala ML,Molina V,Mas R,et al.Antiplatelet effects ofpolicosanol(20 and 40 mg/day)in healthy volunteers and dys-lipidaemic patients[J].Clin and Exp Pharmac Physiol,2002,29(7):891-897.
[10]Menendez R,Mas R,Amor AM,et al.Effects of policosanoltreatment on the susceptibility of low density lipoprotein(LDL)isolated from healthy volunteers to oxidative modificationin vitro[J].Br J Clin Pharmacol,2000,50(3):255-262.
[11]Ng CH,Leung KY,Huanq Y,et al.Policosanol has no antioxi-dant activity in human low-density lipoprotein but increases ex-cretion of bile acids in hamsters[J].Agric Food Chem,2005,53(16):6289-6293.
[12]Varady KA,Wang Y,Jones PJ.Role of policosanols in the pre-vention and treatment of cardiovascular disease[J].Nutr Rev,2003,61(11):376-83.
[13]Menendez R,Fraga V,Amor AM,et al.Oral administration ofpolicosanol inhibitsin vitrocopper ion-induced rat lipoproteinperoxidation[J].Physiol Behav,1999,67(1):1-7.
[14]Noa M,Mas R.Protective effect of policosanol on atheroscleroticplaque on aortas in monkeys[J].Arch Med Res,2005,36(5):441-447.
[15]Menendez R,Amor AM,Rodeiro I,et al.Policosanol modulatesHMG-CoA reductase activity in cultured fibroblasts[J].ArchMed Res,2001,32(1):8-12.
[16]Sinqh DK,Li L,Porter TD.Policosanol inhibits cholesterol syn-thesis in hepatoma cells by activation of AMP-kinase[J].JPharmacol Exp Ther,2006,318(3):1020-1026.
[17]Carbajal D,Arruzazabala ML,Valdes S,et al.Effect of polico-sanol on platelet aggregation and serum levels of arachidonic acidmetabolites in healthy volunteers[J].Prostaglandins Leukot Es-sent Fatty Acids,1998,58(1):61-64.
[18]Noa M,Mas R,Mesa R.A comparative study of policosanol vs.lovastatin on intimal thickening in rabbit cuffed carotid artery[J].Pharmacol Res,2001,43(1):31-37.
[19]Dulin MF,Hatcher LF,Sasser HC,et al.Policosanol is ineffec-tive in the treatment of hypercholesterolemia:a randomized con-trolled trial[J].Am J Clin Nutr,2006,84(6):1543-1548.
【关闭】
